Company Overview and News
The Indian benchmark indices are trading on a positive note this Thursday morning with the Nifty jumping 78 points and is trading above the 11,000 mark while the Sensex is trading higher by 257 points at 36,522, reaching a new record high.
500408 500325 533096 HCTHY 512599 532480 500696 532281 EROSMEDIA GODREJCP CHENNPETRO RLNIY SBAZ ANNRY AXB ALBK YYBKY 532424 AXBA HCLTECH 500180 KOTAKBANK ADANIENT RELIANCE HINDUNILVR 533155 JUBLFOOD 532215 GDRJY 532187 532461 AXISBANK RIGD JBLWY HDFCBANK 500110 YESBANK UBNC INDUSINDBK KMBKY 533261 IBN 532648 AXBKY ICICIBANK PNJZY HDB 532174 TATAELXSI PNB ADANIPOWER 500247
The market is trading on a negative note this Wednesday afternoon, with the Nifty down 21 points at 10,514 and the Sensex down 19 points at 34,631.
IOC 500408 533096 BRTQY TCHQY MARKSANS 532755 PIDILITIND 532483 PDLTY UCLQY 500570 BRITANNIA CHENNPETRO 500331 SBAZ 524404 530965 ULTRACEMCO CNRYY TECHM TATASTEEL TATLY 534809 PCJEWELLER CANBK ANDHRABANK 500825 IDBI 532418 532538 533155 JUBLFOOD 500470 532461 ENGINERSIN JBLWY TATAMOTORS TWL 500110 UBNC 500116 IBN UCLQF 532966 532178 ICICIBANK TTST PNJZY 532174 TATAELXSI PNB ADANIPOWER TTM
The market was trading flat on Monday afternoon, with the Nifty down 59 points at 10,536 and the Sensex down 152 points at 34,695.
500325 500008 BRTQY ICLQY 532955 532712 532832 ARJQY 532960 JUSTDIAL RCOM 532483 AMBUY 534816 532480 500696 AJANTPHARM 500570 BRITANNIA CLNDY CHENNPETRO RLNIY ASHOKLEY SBAZ EXIDEIND TVSMOTOR ALBK CLGQY JETAIRWAYS CANFINHOME 511196 532822 AKLD CNRYY 532234 CASTROLIND EXQDY FORTIS TCS 500103 RECLTD CANBK COALINDIA AKLS NATIONALUM IBREALEST 500825 BHRYY 500425 533150 RELIANCE 532617 KTKBANK HINDUNILVR 532856 BHRQY TTNQY 533278 AMBUJACEM IDBLZ AMARAJABAT CSLQY 532343 532540 535648 532461 CL RIGD INFRATEL 500477 BHARTIARTL TATAMOTORS 500110 500870 IBVENTURES IBN 532843 BHEL 532454 532652 ICICIBANK GODREJPROP 532331 PNJZY 532174 IDEA BRHTY PNB 500086 JSTQY TTM TIMETECHNO
Chennai Petroleum Corporation has been given in-principle approval for its Rs 27,000 crore refinery expansion project in Tamil Nadu, a top official said today.
IOC 530965 500110 CHENNPETRO
India's biggest oil firm IOC today said it plans to invest about Rs 1.43 lakh crore to nearly double its oil refining capacity to 150 million tonnes and boost petrochemical production by 2030.
New Delhi: India’s biggest oil firm IOC on Saturday said it plans to invest about Rs1.43 trillion to nearly double its oil refining capacity to 150 million tonnes and boost petrochemical production by 2030.
IOC 530965 500110 CHENNPETRO
The Indian equity market was trading almost flat on Monday morning with the Nifty trading lower by 9 points, trading below the 10,000 mark at 9988 while the Sensex was up 25 points or 0.08 percent.
IOC CAPF TCHQY 532755 CADILAHC 532321 BJJQY GAILF 500570 CHENNPETRO SBAZ PTC YYBKY 530965 TECHM BAJFINANCE TATASTEEL TATLY GAMMONIND GAILY 509550 TCS 523204 532938 IDBI 533155 TTNQY JUBLFOOD ABAN 500470 532540 532187 532461 JBLWY SKFINDIA TATAMOTORS 500472 500110 500034 YESBANK UBNC 500116 INDUSINDBK IBN 532648 532524 CDLYY ICICIBANK TTST PNJZY 532174 PNB TTM
2018-07-17 - Asif
History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...
2018-07-17 - Asif
Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...
2018-07-16 - Asif
General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...